BackgroundIn COVID-19 pneumonia, chest CT scan plays a crucial role in diagnosing and closely monitoring lung parenchyma. The main reportedly chest CT features of novel coronavirus pneumonia (NCP) ...have been fully discussed in the literature, but there is still a paucity of reports on uncommon CT manifestations. Case presentationHerewith, we have reported ten rRT-PCR confirmed COVID-19 patients with CT target signs (bull's eye appearance); additionally, we have reviewed previously reported cases. Reviewing the literature, we found eight COVID-19 patients with target sign in the literature. 18 patients were included with a median age of 43. 11 (61%) patients were males. In 87% of patients, the lesions developed within the second-week post symptom onset. These patients mostly experienced an extended hospital stay (median = 10 days), with 53.8% of cases being admitted in ICU. The in-hospital mortality rate was 23%. ConclusionOur findings indicate that lesions with a bull's eye appearance are not significantly associated with higher mortality in hospitalized COVID-19 patients.
COVID-19 is a virus with high transmission rate that demands rapid identification of the infected patients to reduce the spread of the disease. The current gold-standard test, Reverse-Transcription ...Polymerase Chain Reaction (RT-PCR), has a high rate of false negatives. Diagnosing from CT-scan images as a more accurate alternative has the challenge of distinguishing COVID-19 from other pneumonia diseases. Artificial intelligence can help radiologists and physicians to accelerate the process of diagnosis, increase its accuracy, and measure the severity of the disease. We designed a new interpretable deep neural network to distinguish healthy people, patients with COVID-19, and patients with other pneumonia diseases from axial lung CT-scan images. Our model also detects the infected areas and calculates the percentage of the infected lung volume. We first preprocessed the images to eliminate the batch effects of different devices, and then adopted a weakly supervised method to train the model without having any tags for the infected parts. We trained and evaluated the model on a large dataset of 3359 samples from 6 different medical centers. The model reached sensitivities of 97.75% and 98.15%, and specificities of 87% and 81.03% in separating healthy people from the diseased and COVID-19 from other diseases, respectively. It also demonstrated similar performance for 1435 samples from 6 different medical centers which proves its generalizability. The performance of the model on a large diverse dataset, its generalizability, and interpretability makes it suitable to be used as a reliable diagnostic system.